Successful test in breast cancer patients: the active agent digoxin, a cardiac medication, dissolves clusters of circulating breast cancer cells in the blood, thus reducing the risk of metastases ...
Virginia G. Kaklamani, MD, DSc, discusses datopotamab deruxtecan and other antibody-drug conjugates available for patients with unresectable or metastatic hormone receptor-positive, HER2-negative ...
Certain tumor types do not remain at their point of origin but spread throughout the body and form metastases. This is ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.
With medical advances, more than 169,000 people in the United States are living with metastatic breast cancer.
A clinical trial demonstrates the effectiveness of telephone-delivered acceptance and commitment therapy (ACT) in reducing fatigue's interference with functioning and improving the quality of life for ...
After getting a metastatic breast cancer diagnosis, you may experience anxiety and depression. Here are some ways to manage ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
The approval was based on results from the TROPION-Breast01 Phase III trial.
If you have been diagnosed with metastatic breast cancer, resources like support groups, counseling, financial assistance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback